457 results found

Despite headwinds, private equity (PE) activity in Ireland in 2022 continued to be strong with a total of 62 transactions. In line with overall M&A, PE activity in Ireland failed to maintain the exceptional...

By value, TMT deals accounted for 79% of all activity during the first half of the year, helped in large part by Apollo's investment in Intel Corporation which alone accounted for 57%.

ILP: the ILP is a regulated limited partnership structure used as a structuring solution for private equity strategies and an alternative to the Luxembourg SCSp.

The Irish Government has published the Investment Limited Partnerships (Amendment) Bill 2020.

This second article in a two-part series identifies upcoming requirements associated with the Taxonomy Regulation, as well as certain challenges when attempting to simultaneously comply with SFDR and MiFID II.

There has been a global decline in M&A deal value this year due to rising interest rates, tighter bank lending, recession fears and inflation. According to a recent report in the Financial Times, global dealmaking...

Despite global economic uncertainties and geopolitical tensions, Ireland's M&A market demonstrated remarkable resilience in 2024. Irish M&A deal value for 2024 reached €27.5bn, an increase of 115% on 2023 figures.

Matheson LLP has advised on over 40% more financial services M&A transactions than any other Irish law firm. The firm advised on 13 financial services M&A deals over the course of 2022.

The Dublin office of leading international law firm, Maples and Calder, recently advised Cantor Fitzgerald on its agreement to acquire Merrion Capital Group.

Large transactions remain the exception rather than the norm in Ireland, with M&A activity continuing to be dominated by the mid-market.

Under Irish merger control rules, mergers or acquisitions which meet certain financial thresholds require competition clearance from the Competition and Consumer Protection Commission (CCPC).

The number of M&A deals involving a PE investor decreased in 2023 with 58 transactions announced, down 11% from 2022; these were collectively worth €2.2bn, down 33% on the previous year.

Arthur Cox's Life Sciences Outlook 2026 examines critical regulatory developments and strategic opportunities shaping Ireland's life sciences sector. The publication explores Ireland's EU Council Presidency and its potential impact on advancing key legislative initiatives including the Biotech Act I and medical device reforms. Industry leaders will find comprehensive analysis spanning pharmaceutical compliance, medtech regulation, data governance, M&A activity, and environmental considerations.

ComReg took the somewhat unusual step of publicly stating that it "remains concerned" about the effects of the merger on Irish consumers.

In a significant development for companies with EU operations, the Mobility Directive (Directive (EU) 2019/2121) has been transposed into Irish law.

The Central Bank of Ireland (CBI) and the Securities and Futures Commission of Hong Kong (SFC) entered into a Memorandum of Understanding on 14 May 2025 establishing a framework for the mutual recognition...

The Irish competition regulator (the "CCPC") has a track record of requiring behavioural remedies in merger cases which has been continued in the recent CCPC case of Pandagreen / Knockharley Landfill and Natureford.